“anticipate a gradual erosion curve that allows Darzalex to remain a meaningful revenue contributor well into the next decade.”

UBS · said 2026-09-02 · reported 2026-09-03

UBS argued that Darzalex's patent expiration should be more of a hill than a cliff.